Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groups.
about
High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocolNew and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemiaChildhood acute lymphoblastic leukemia: Integrating genomics into therapySmall sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL.Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoprotein.Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.Genomics in acute lymphoblastic leukaemia: insights and treatment implications.Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.CRLF2-Positive B-Cell Acute Lymphoblastic Leukemia in Adult Patients: A Single-Institution Experience.Prognostic significance of P2RY8-CRLF2 and CRLF2 overexpression may vary across risk subgroups of childhood B-cell acute lymphoblastic leukemia.Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia.Prognostic significance of cytokine receptor-like factor 2 alterations in acute lymphoblastic leukemia: a meta-analysis.Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemia.Philadelphia chromosome-like acute lymphoblastic leukemia.No prognostic impact of P2RY8-CRLF2 fusion in intermediate cytogenetic risk childhood B-cell acute lymphoblastic leukaemia.Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in children.AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia.Surface expression of Cytokine Receptor-Like Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring IKZF1 deletions.
P2860
Q23749304-9B8D82E2-1CC5-4136-A81F-5BD64ABE5080Q26749177-CBA0C144-5B1D-41E2-8A94-077236670831Q28080463-5F09F54C-FF22-472F-86CB-C683DDEDA4C1Q34325528-C31B1D2F-7E20-4DA6-A797-30E19127F772Q35904943-4D30A24F-021B-4114-A53F-3A7D4863B10DQ37226741-60D25BFA-9435-40C1-A486-2DB2DFF2EFA4Q38381463-2A65F4CB-1A14-4F5A-9A99-65C4E7B6125AQ39041475-08665C47-2829-4E56-B723-BB9B46E55395Q40275129-45C40437-8044-4EE2-B9B3-B2F9DE6CED0EQ40537705-03470092-7FDA-4621-A0C9-BEB245A86204Q41000106-2A70E0D4-E86E-4631-B9F5-B0FDCEA015CBQ41003977-697E0BA0-B7F0-49A0-AF6C-478DBE1A22D5Q42847773-34BB2A1B-A891-436B-BAA2-6EA52E748BA9Q43431904-02C4ED90-8AB8-436D-BC6E-76D1865E4149Q46208779-5AA03759-9B36-453B-BEF4-F873E08BBCD9Q46711660-343C9C69-C34A-4283-824B-45A131660B22Q47203054-3193F065-2649-4666-82A5-0BE0749E02FAQ47976103-1D0CA3D1-A0D3-4E2B-B6DA-A00B964D1010Q55346725-0511BBC1-2246-4D18-B5E7-ACD4BE1E8CA4
P2860
Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groups.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Treatment outcome of CRLF2-rea ...... and UK NCRI-CCLG study groups.
@en
Treatment outcome of CRLF2-rea ...... and UK NCRI-CCLG study groups.
@nl
type
label
Treatment outcome of CRLF2-rea ...... and UK NCRI-CCLG study groups.
@en
Treatment outcome of CRLF2-rea ...... and UK NCRI-CCLG study groups.
@nl
prefLabel
Treatment outcome of CRLF2-rea ...... and UK NCRI-CCLG study groups.
@en
Treatment outcome of CRLF2-rea ...... and UK NCRI-CCLG study groups.
@nl
P2093
P2860
P50
P1476
Treatment outcome of CRLF2-rea ...... and UK NCRI-CCLG study groups.
@en
P2093
Andishe Attarbaschi
Associazione Italiana di Emato ...... d Leukaemia (CCLG) Study Group
Chiara Palmi
Christopher D Mitchell
Claire Schwab
Elena Vendramini
Georg Mann
Giovanni Cazzaniga
Gunnar Cario
Hannah M Ensor
P2860
P304
P356
10.1111/J.1365-2141.2012.09221.X
P407
P50
P577
2012-07-23T00:00:00Z